左心室辅助装置在心力衰竭治疗中的应用
Left Ventricular Assist Devices in the Management of Heart Failure.
作者信息
Y Birati Edo, Jessup Mariell
机构信息
Cardiovascular Division, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania.
出版信息
Card Fail Rev. 2015 Apr;1(1):25-30. doi: 10.15420/CFR.2015.01.01.25.
Abstract
Mechanical circulatory support has emerged as an important therapy for advanced heart failure, with more than 18,000 continuous flow devices implanted worldwide to date. These devices significantly improve survival and quality of life and should be considered in every patient with end-stage heart failure with reduced ejection fraction who has no other life-limiting diseases. All candidates for device implantation should undergo a thorough evaluation in order to identify those who could benefit from device implantation. Long-term management of ventricular assist device patients is challenging and requires knowledge of the characteristic complications with their unique clinical presentations.
摘要
机械循环支持已成为晚期心力衰竭的重要治疗方法，迄今为止全球已植入超过18000台连续血流装置。这些装置显著提高了生存率和生活质量，对于每一位射血分数降低的终末期心力衰竭且无其他危及生命疾病的患者都应予以考虑。所有装置植入候选人都应接受全面评估，以确定那些能从装置植入中获益的人。心室辅助装置患者的长期管理具有挑战性，需要了解其独特临床表现的特征性并发症。
相似文献
1
Left Ventricular Assist Devices in the Management of Heart Failure.
Card Fail Rev. 2015 Apr;1(1):25-30. doi: 10.15420/CFR.2015.01.01.25.
2
Ethical challenges with the left ventricular assist device as a destination therapy.
Philos Ethics Humanit Med. 2008 Aug 11;3:20. doi: 10.1186/1747-5341-3-20.
3
Left ventricular assist devices: an evidence-based analysis.
Ont Health Technol Assess Ser. 2004;4(3):1-69. Epub 2004 Mar 1.
4
Advanced heart failure treated with continuous-flow left ventricular assist device.
N Engl J Med. 2009 Dec 3;361(23):2241-51. doi: 10.1056/NEJMoa0909938. Epub 2009 Nov 17.
5
Derivation and Validation of a Novel Right-Sided Heart Failure Model After Implantation of Continuous Flow Left Ventricular Assist Devices: The EUROMACS (European Registry for Patients with Mechanical Circulatory Support) Right-Sided Heart Failure Risk Score.
Circulation. 2018 Feb 27;137(9):891-906. doi: 10.1161/CIRCULATIONAHA.117.030543. Epub 2017 Aug 27.
6
Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
J Thorac Cardiovasc Surg. 2014 Sep;148(3):1115-21; discussion 1021-2. doi: 10.1016/j.jtcvs.2014.05.063. Epub 2014 Jun 6.
7
Cardiac extracorporeal life support: state of the art in 2007.
Cardiol Young. 2007 Sep;17 Suppl 2:104-15. doi: 10.1017/S1047951107001217.
8
Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011.
J Thorac Cardiovasc Surg. 2013 Aug;146(2):437-41.e1. doi: 10.1016/j.jtcvs.2013.02.018. Epub 2013 Mar 13.
9
Ventricular assist device for end-stage adult congenital heart disease patients: Current status.
J Cardiol. 2023 Apr;81(4):378-384. doi: 10.1016/j.jjcc.2022.09.007. Epub 2022 Sep 21.
10
Ventricular assist device: saving the failing heart.
Prog Transplant. 2010 Jun;20(2):134-41. doi: 10.1177/152692481002000207.
引用本文的文献
1
Metabolic Consequences of Advanced Chronic Heart Failure and its Modification by Implantation of a Durable Left Ventricular Assist Device.
Rev Cardiovasc Med. 2024 Oct 31;25(11):388. doi: 10.31083/j.rcm2511388. eCollection 2024 Nov.
2
CoronaVac, BNT162b2 and heterologous COVID-19 vaccine outcomes in patients with ventricular assist device.
Int J Artif Organs. 2023 Jan;46(1):15-21. doi: 10.1177/03913988221141719. Epub 2022 Dec 9.
3
Virtual reality-guided left ventricular assist device implantation in pediatric patient: Valuable presurgical tool.
Ann Pediatr Cardiol. 2021 Jul-Sep;14(3):388-392. doi: 10.4103/apc.apc_81_21. Epub 2021 Aug 17.
4
Characteristics and Outcomes of COVID-19 in Patients on Left Ventricular Assist Device Support.
Circ Heart Fail. 2021 Apr;14(4):e007957. doi: 10.1161/CIRCHEARTFAILURE.120.007957. Epub 2021 Apr 5.
5
The Impact of Obesity on Left Ventricular Assist Device Outcomes.
Medicina (Kaunas). 2020 Oct 23;56(11):556. doi: 10.3390/medicina56110556.
6
Left Ventricular Assist Device Support Complicates the Exercise Physiology of Oxygen Transport and Uptake in Heart Failure.
Card Fail Rev. 2019 Nov 4;5(3):162-168. doi: 10.15420/cfr.2019.10.2. eCollection 2019 Nov.
7
Left Ventricular Assist Device as Destination Therapy: a State of the Science and Art of Long-Term Mechanical Circulatory Support.
Curr Heart Fail Rep. 2019 Oct;16(5):168-179. doi: 10.1007/s11897-019-00438-x.
8
Retrospective Evaluation of Bayesian Risk Models of LVAD Mortality at a Single Implant Center.
Front Med (Lausanne). 2018 Oct 2;5:277. doi: 10.3389/fmed.2018.00277. eCollection 2018.
9
CSI position statement on management of heart failure in India.
Indian Heart J. 2018 Jul;70 Suppl 1(Suppl 1):S1-S72. doi: 10.1016/j.ihj.2018.05.003. Epub 2018 Jun 8.
本文引用的文献
1
Left atrial decompression pump for severe heart failure with preserved ejection fraction: theoretical and clinical considerations.
JACC Heart Fail. 2015 Apr;3(4):275-82. doi: 10.1016/j.jchf.2014.10.011. Epub 2015 Mar 11.
2
Ventricular assist device thrombosis: A wide spectrum of clinical presentation.
J Heart Lung Transplant. 2015 Apr;34(4):613-5. doi: 10.1016/j.healun.2014.12.007. Epub 2014 Dec 24.
3
Diagnosis and Management of LVAD Thrombosis.
Curr Treat Options Cardiovasc Med. 2015 Feb;17(2):361. doi: 10.1007/s11936-014-0361-y.
4
Preoperative three-dimensional echocardiography to assess risk of right ventricular failure after left ventricular assist device surgery.
J Card Fail. 2015 Mar;21(3):189-97. doi: 10.1016/j.cardfail.2014.12.009. Epub 2014 Dec 20.
5
Pathologic von Willebrand factor degradation with a left ventricular assist device occurs via two distinct mechanisms: mechanical demolition and enzymatic cleavage.
J Thorac Cardiovasc Surg. 2015 Jan;149(1):281-9. doi: 10.1016/j.jtcvs.2014.09.031. Epub 2014 Sep 18.
6
Determinants of the direct cost of heart failure hospitalization in a public tertiary hospital.
Int J Cardiol. 2015 Feb 1;180:46-9. doi: 10.1016/j.ijcard.2014.11.123. Epub 2014 Nov 26.
7
Current practice in patient selecting for long-term mechanical circulatory support.
Curr Heart Fail Rep. 2015 Apr;12(2):120-9. doi: 10.1007/s11897-014-0243-3.
8
The MVAD pump: motor stator core loss characterization.
ASAIO J. 2015 Mar-Apr;61(2):122-6. doi: 10.1097/MAT.0000000000000180.
9
Post-heart transplant complications.
Crit Care Clin. 2014 Jul;30(3):629-37. doi: 10.1016/j.ccc.2014.03.005.
10
Left ventricular assist device management and complications.
Crit Care Clin. 2014 Jul;30(3):607-27. doi: 10.1016/j.ccc.2014.04.001.
Zotero 插件